4-Hydroxytamoxifen-induced cytotoxicity and bisphenol A: Competition for estrogen receptors in human breast cancer cell lines

Jill B. Lewis, Carol A. Lapp, Tara E Schafer, John C. Wataha, Tabitha M. Randol, George S. Schuster

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Increasing concerns over the effects of environmental estrogens on wildlife and humans have highlighted the need for screening systems to assess potentially estrogenic effects of test compounds. As a result, in vitro screening methods such as cell proliferation assays using the estrogen-responsive human breast cancer cell line, MCF-7, have been developed. The present study describes an alternative in vitro approach for the assessment of such xenoestrogens, based on estrogenic rescue of MCF-7 cells from antiestrogen-induced cytotoxicity. This method measures the ability of various estrogenic compounds to compete with a known estrogen-receptor-mediated antihormonal drug, 4-hydroxytamoxifen, using the 1-[4,5-dimethylthiazol-2-yl]- 3,5-diphenylformazan (MTT) assay to assess mitochondrial activity. Because 4-hydroxytamoxifen treatment of cells results in a dramatic decrease in mitochondrial dehydrogenase activity which is directly related to their estrogen-receptor content, inhibition of this effect with estrogenic compounds represents an estrogen-receptor interaction, or estrogenic rescue. The estrogenic compounds tested include a weak xenoestrogen, bisphenol A (BPA), and two biological estrogens, 17α- and 17β-estradiol. Competitive inhibition of 4-hydroxytamoxifen-induced cytotoxicity by BPA was compared to that of the biological estrogens. The results indicate that the biological estrogens can successfully compete with the antiestrogen in a dose-dependent manner. In addition, the assay is sensitive enough to detect estrogenic rescue by even the very weak xenoestrogen, BPA, albeit at high BPA concentrations. This simple in vitro method could be used as an alternative or second-line screen for potential xenoestrogens.

Original languageEnglish (US)
Pages (from-to)320-326
Number of pages7
JournalIn Vitro Cellular and Developmental Biology - Animal
Volume36
Issue number5
StatePublished - May 1 2000

Fingerprint

Estrogen Receptors
Estrogens
Breast Neoplasms
Cell Line
Estrogen Receptor Modulators
afimoxifene
bisphenol A
MCF-7 Cells
Estradiol
Oxidoreductases
Cell Proliferation
Pharmaceutical Preparations
In Vitro Techniques

Keywords

  • Biocompatibility
  • Dental sealants and composites
  • MCF-7
  • Xenoestrogen

ASJC Scopus subject areas

  • Developmental Biology
  • Cell Biology

Cite this

4-Hydroxytamoxifen-induced cytotoxicity and bisphenol A : Competition for estrogen receptors in human breast cancer cell lines. / Lewis, Jill B.; Lapp, Carol A.; Schafer, Tara E; Wataha, John C.; Randol, Tabitha M.; Schuster, George S.

In: In Vitro Cellular and Developmental Biology - Animal, Vol. 36, No. 5, 01.05.2000, p. 320-326.

Research output: Contribution to journalArticle

Lewis, Jill B. ; Lapp, Carol A. ; Schafer, Tara E ; Wataha, John C. ; Randol, Tabitha M. ; Schuster, George S. / 4-Hydroxytamoxifen-induced cytotoxicity and bisphenol A : Competition for estrogen receptors in human breast cancer cell lines. In: In Vitro Cellular and Developmental Biology - Animal. 2000 ; Vol. 36, No. 5. pp. 320-326.
@article{b953c0fe6986499a9cba35d0d64d19cd,
title = "4-Hydroxytamoxifen-induced cytotoxicity and bisphenol A: Competition for estrogen receptors in human breast cancer cell lines",
abstract = "Increasing concerns over the effects of environmental estrogens on wildlife and humans have highlighted the need for screening systems to assess potentially estrogenic effects of test compounds. As a result, in vitro screening methods such as cell proliferation assays using the estrogen-responsive human breast cancer cell line, MCF-7, have been developed. The present study describes an alternative in vitro approach for the assessment of such xenoestrogens, based on estrogenic rescue of MCF-7 cells from antiestrogen-induced cytotoxicity. This method measures the ability of various estrogenic compounds to compete with a known estrogen-receptor-mediated antihormonal drug, 4-hydroxytamoxifen, using the 1-[4,5-dimethylthiazol-2-yl]- 3,5-diphenylformazan (MTT) assay to assess mitochondrial activity. Because 4-hydroxytamoxifen treatment of cells results in a dramatic decrease in mitochondrial dehydrogenase activity which is directly related to their estrogen-receptor content, inhibition of this effect with estrogenic compounds represents an estrogen-receptor interaction, or estrogenic rescue. The estrogenic compounds tested include a weak xenoestrogen, bisphenol A (BPA), and two biological estrogens, 17α- and 17β-estradiol. Competitive inhibition of 4-hydroxytamoxifen-induced cytotoxicity by BPA was compared to that of the biological estrogens. The results indicate that the biological estrogens can successfully compete with the antiestrogen in a dose-dependent manner. In addition, the assay is sensitive enough to detect estrogenic rescue by even the very weak xenoestrogen, BPA, albeit at high BPA concentrations. This simple in vitro method could be used as an alternative or second-line screen for potential xenoestrogens.",
keywords = "Biocompatibility, Dental sealants and composites, MCF-7, Xenoestrogen",
author = "Lewis, {Jill B.} and Lapp, {Carol A.} and Schafer, {Tara E} and Wataha, {John C.} and Randol, {Tabitha M.} and Schuster, {George S.}",
year = "2000",
month = "5",
day = "1",
language = "English (US)",
volume = "36",
pages = "320--326",
journal = "In Vitro Cellular and Developmental Biology - Animal",
issn = "1071-2690",
publisher = "Springer New York",
number = "5",

}

TY - JOUR

T1 - 4-Hydroxytamoxifen-induced cytotoxicity and bisphenol A

T2 - Competition for estrogen receptors in human breast cancer cell lines

AU - Lewis, Jill B.

AU - Lapp, Carol A.

AU - Schafer, Tara E

AU - Wataha, John C.

AU - Randol, Tabitha M.

AU - Schuster, George S.

PY - 2000/5/1

Y1 - 2000/5/1

N2 - Increasing concerns over the effects of environmental estrogens on wildlife and humans have highlighted the need for screening systems to assess potentially estrogenic effects of test compounds. As a result, in vitro screening methods such as cell proliferation assays using the estrogen-responsive human breast cancer cell line, MCF-7, have been developed. The present study describes an alternative in vitro approach for the assessment of such xenoestrogens, based on estrogenic rescue of MCF-7 cells from antiestrogen-induced cytotoxicity. This method measures the ability of various estrogenic compounds to compete with a known estrogen-receptor-mediated antihormonal drug, 4-hydroxytamoxifen, using the 1-[4,5-dimethylthiazol-2-yl]- 3,5-diphenylformazan (MTT) assay to assess mitochondrial activity. Because 4-hydroxytamoxifen treatment of cells results in a dramatic decrease in mitochondrial dehydrogenase activity which is directly related to their estrogen-receptor content, inhibition of this effect with estrogenic compounds represents an estrogen-receptor interaction, or estrogenic rescue. The estrogenic compounds tested include a weak xenoestrogen, bisphenol A (BPA), and two biological estrogens, 17α- and 17β-estradiol. Competitive inhibition of 4-hydroxytamoxifen-induced cytotoxicity by BPA was compared to that of the biological estrogens. The results indicate that the biological estrogens can successfully compete with the antiestrogen in a dose-dependent manner. In addition, the assay is sensitive enough to detect estrogenic rescue by even the very weak xenoestrogen, BPA, albeit at high BPA concentrations. This simple in vitro method could be used as an alternative or second-line screen for potential xenoestrogens.

AB - Increasing concerns over the effects of environmental estrogens on wildlife and humans have highlighted the need for screening systems to assess potentially estrogenic effects of test compounds. As a result, in vitro screening methods such as cell proliferation assays using the estrogen-responsive human breast cancer cell line, MCF-7, have been developed. The present study describes an alternative in vitro approach for the assessment of such xenoestrogens, based on estrogenic rescue of MCF-7 cells from antiestrogen-induced cytotoxicity. This method measures the ability of various estrogenic compounds to compete with a known estrogen-receptor-mediated antihormonal drug, 4-hydroxytamoxifen, using the 1-[4,5-dimethylthiazol-2-yl]- 3,5-diphenylformazan (MTT) assay to assess mitochondrial activity. Because 4-hydroxytamoxifen treatment of cells results in a dramatic decrease in mitochondrial dehydrogenase activity which is directly related to their estrogen-receptor content, inhibition of this effect with estrogenic compounds represents an estrogen-receptor interaction, or estrogenic rescue. The estrogenic compounds tested include a weak xenoestrogen, bisphenol A (BPA), and two biological estrogens, 17α- and 17β-estradiol. Competitive inhibition of 4-hydroxytamoxifen-induced cytotoxicity by BPA was compared to that of the biological estrogens. The results indicate that the biological estrogens can successfully compete with the antiestrogen in a dose-dependent manner. In addition, the assay is sensitive enough to detect estrogenic rescue by even the very weak xenoestrogen, BPA, albeit at high BPA concentrations. This simple in vitro method could be used as an alternative or second-line screen for potential xenoestrogens.

KW - Biocompatibility

KW - Dental sealants and composites

KW - MCF-7

KW - Xenoestrogen

UR - http://www.scopus.com/inward/record.url?scp=0033868657&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033868657&partnerID=8YFLogxK

M3 - Article

C2 - 10937835

AN - SCOPUS:0033868657

VL - 36

SP - 320

EP - 326

JO - In Vitro Cellular and Developmental Biology - Animal

JF - In Vitro Cellular and Developmental Biology - Animal

SN - 1071-2690

IS - 5

ER -